Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments (2022)
- Authors:
- Magalhães, Lucas Sousa
- Melo, Enaldo Vieira
- Damascena, Nayra Prata
- Albuquerque, Adriana Cardoso Batista
- Santos, Camilla Natália Oliveira
- Rebouças, Mônica Cardozo
- Bezerra, Mariana de Oliveira
- Silva, Ricardo Louzada da
- Oliveira, Fabricia Alvisi de
- Santos, Priscila Lima
- Silva, João Santana da
- Lipscomb, Michael Wheeler
- Silva, Ângela Maria da
- Jesus, Amélia Ribeiro de
- Almeida, Roque Pacheco de
- Autor USP: SILVA, JOÃO SANTANA DA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fcimb.2022.1045668
- Subjects: LEISHMANIOSE VISCERAL; QUIMIOTERAPIA ADJUVANTE; FARMACOTERAPIA; INTERLEUCINA 10; LEUCÓCITOS MONONUCLEARES
- Keywords: N-acetyl-l-cysteine; Adjuvant chemotherapy; Drug therapy; Meglumine antimoniate; Visceral leishmaniasis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Cellular and Infection Microbiology
- ISSN: 2235-2988
- Volume/Número/Paginação/Ano: v. 12, art. 1045668, [10] p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MAGALHÃES, Lucas Sousa et al. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments. Frontiers in Cellular and Infection Microbiology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.1045668. Acesso em: 04 ago. 2025. -
APA
Magalhães, L. S., Melo, E. V., Damascena, N. P., Albuquerque, A. C. B., Santos, C. N. O., Rebouças, M. C., et al. (2022). Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments. Frontiers in Cellular and Infection Microbiology, 12. doi:10.3389/fcimb.2022.1045668 -
NLM
Magalhães LS, Melo EV, Damascena NP, Albuquerque ACB, Santos CNO, Rebouças MC, Bezerra M de O, Silva RL da, Oliveira FA de, Santos PL, Silva JS da, Lipscomb MW, Silva ÂM da, Jesus AR de, Almeida RP de. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2025 ago. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.1045668 -
Vancouver
Magalhães LS, Melo EV, Damascena NP, Albuquerque ACB, Santos CNO, Rebouças MC, Bezerra M de O, Silva RL da, Oliveira FA de, Santos PL, Silva JS da, Lipscomb MW, Silva ÂM da, Jesus AR de, Almeida RP de. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2025 ago. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.1045668 - Activity of the 1,4 and 1,2 naphthoquinones derivatives on blood stream forms of trypanosoma cruzi
- Importance of macrophage activation and reactivation in t. Cruzi infection
- Il-10 mediates susceptibility to trypanosoma cruzi infection
- Papel da il-12 na infeccao experimental por trypanosoma cruzi
- Natural killer cells do not play an important role in murine infection with low virulent strain of paracoccidioides brasiliensis
- Role of endogenous IL-12 and IFN-gamma on efficacy of benznidazole to treat experimental infection with Trypanosoma cruzi
- Platelet activating factor (PAF) induces nitric oxide synthesis in Trypanosama cruzi infected macrophages and mediates resistance to parasite infection in mice
- Detecção de apoptose, e expressão CD95 e CD95-L em timócitos de camundongos infectados com Trypanosoma cruzi
- Tick antigens that elicit potent cellular responses in resistant but not susceptible animals: towards development of tick vaccines
- Participação de citocinas no determinismo de resistência ou susceptibilidade à infecção experimental por Trypanosoma cruzi
Informações sobre o DOI: 10.3389/fcimb.2022.1045668 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003138407.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
